Clinical trial NCT03912467: Prevalence of Pressure Ulcers Among Critically Ill Patients and Factors Associated With Their Occurrence in the ICU
Official title: Prevalence of Pressure Ulcers Among Critically Ill Patients and Factors Associated With Their Occurrence in the ICU
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Pressure Ulcer
Critical Care
Intensive Care Unit Syndrome
Lead sponsor: French Society for Intensive Care
Sponsor class: OTHER
First posted: 2019-04-11
Enrollment: 1228
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Observational model: COHORT
Time perspective: RETROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patient in Critical Care during study day.

Brief summary: The prevalence of and risk factors for pressure ulcers (PUs) in critically ill patients have been poorly studied. The main objective of this study was to describe the prevalence of PUs in critically ill patients. Secondary objectives were to describe PUs, means of prevention of PUs, and factors associated with occurrence of PUs in the ICU.

Detailed description: Pressure ulcers (PUs) among hospitalized patients are associated with a poor prognosis and with a high cost of care. Hospitalization in the ICU is a context where there is a high risk of occurrence of PUs, prevention of which is a priority for ICU teams caring for critically ill patients. However, the literature is inconclusive regarding the prevalence of PUs among critically ill patients and the associated risk factors. The main objective of this study was to describe the prevalence of PUs among critically ill patients hospitalized in the ICU. Secondary objectives were to describe means of prevention of PUs in the ICU and the characteristics of PUs, and to identify factors either related to the ICU or patient characteristics associated with occurrence of PUs in the ICU.

Eligibility criteria: The inclusion criteria were :

* hospitalization in the ICU
* age ≥ 18 years.

The exclusion criterion was:

- refusal to participate in the study by the patient or by the patient's family when the patient was unable to consent.

Primary outcomes:
measure: Pressure Ulcer Presence on the study day
timeFrame: Through study completion, an average of 1 day
Secondary outcomes:
measure: Grade of Pressure Ulcer on the study day
timeFrame: Through study completion, an average of 1 day
measure: Area of Pressure Ulcer on the study day
timeFrame: Through study completion, an average of 1 day
Other outcomes:
Locations:
city: Agen
country: France
facility: Hôpital Saint-Esprit
city: Angers
country: France
facility: CHU d'Angers
city: Antony
country: France
facility: Hopital Privé d'Antony
city: Ars-Laquenexy
country: France
facility: Hopital Mercy
city: Belfort
country: France
facility: Hopital Nord Franche Comté
city: Bobigny
country: France
facility: Hopital Avicenne
city: Bordeaux
country: France
facility: CHU Pellegrin
city: Bordeaux
country: France
facility: Hopital St-Andre
city: Boulogne Billancourt
country: France
facility: Hopital Ambroise Pare
city: Brest
country: France
facility: HIA Clermont Tonnerre
city: Clamart
country: France
facility: Hopital Antoine Beclere
city: Clamart
country: France
facility: HIA Percy
city: Colombes
country: France
facility: Hopital Louis Mourier
city: Corbeil-Essonnes
country: France
facility: Groupe Hospitalier Sud Ile de France
city: Cornebarrieu
country: France
facility: Clinique des Cèdres
city: Creteil
country: France
facility: CHU Henri Mondor
city: Dijon
country: France
facility: CHU Dijon Bourgogne
city: Eaubonne
country: France
facility: Hopital Simone Veil
city: Garches
country: France
facility: Hopital Raymond Poincare
city: Grenoble
country: France
facility: CHU Grenoble Alpes
city: Jossigny
country: France
facility: Grand Hopital de l'Est Francilien
city: La Réunion
country: France
facility: CHU Réunion Saint Pierre
city: Le Kremlin-Bicêtre
country: France
facility: CHU Kremlin-Bicetre
city: Lille
country: France
facility: Hopital Roger Salengro
city: Lyon
country: France
facility: HIA Desgenettes Lyon
city: Lyon
country: France
facility: Groupe Hospitalier Edouard Herriot
city: Mantes-la-Jolie
country: France
facility: Hopital Francois Quesnay
city: Marseille
country: France
facility: Hopital Européen Marseille
city: Marseille
country: France
facility: CHU Marseille Hopital Nord
city: Marseille
country: France
facility: Hopital de la Timone
city: Metz
country: France
facility: Hopital Notre-Dame de Bon Secours
city: Montfermeil
country: France
facility: GHIRM
city: Montpellier
country: France
facility: CHU Lapeyronie
city: Nancy
country: France
facility: CHU Nancy
city: Nantes
country: France
facility: CHU Nantes
city: Nantes
country: France
facility: Hopital Laennec
city: Nice
country: France
facility: Hopital l'Archet
city: Nîmes
country: France
facility: CHU Nimes
city: Paris
country: France
facility: Hopital St Louis
city: Paris
country: France
facility: GH Diaconnesses Croix Saint Simon
city: Paris
country: France
facility: La Pitié Salpetriere
city: Paris
country: France
facility: Cochin
city: Paris
country: France
facility: Institut Mutualiste Montsouris
city: Paris
country: France
facility: CHU Necker Enfants Malades
city: Paris
country: France
facility: CHU Robert Debré
city: Paris
country: France
facility: HEGP
city: Paris
country: France
facility: Hopital Tenon
city: Poitiers
country: France
facility: CHU Poitiers
city: Quincy-sous-Sénart
country: France
facility: Hopital Privé Claude Galien
city: Saint-Jean
country: France
facility: Clinique de l'Union
city: St-Denis
country: France
facility: Hopital Delafontaine
city: St-Mande
country: France
facility: HIA Béjin
city: Strasbourg
country: France
facility: CHU Strasbourg
city: Sète
country: France
facility: Hopital Saint Clair
city: Toulouse
country: France
facility: CHU Toulouse Rangueil
city: Tremblay-en-France
country: France
facility: Hopital Privé du Vert Galan
city: Valenciennes
country: France
facility: Hopital Jean Bernard
city: Villejuif
country: France
facility: Institut Gustave Roussy
city: Villenave-d'Ornon
country: France
facility: HIA Robert Pique
city: Yerres
country: France
facility: Hopital Privé du Val d'Yerres
Study officials:
affiliation: French Intensive Care Society
name: Gael Piton, MD, PhD
role: STUDY_CHAIR
References: